{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-120164","form_type":"8-K","ticker":"AARD","cik":"0001774857","company_name":"Aardvark Therapeutics, Inc.","filed_at":"2026-03-24T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.134602+00:00","generated_at":"2026-05-15T09:14:08.095681+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Aardvark enters $150M equity distribution agreement with Piper Sandler","bullets":["May sell up to $150M of common stock at market through Piper Sandler as agent.","Commission of 3.0% of gross sales price per share sold under agreement.","Company has no obligation to sell any shares; sales at Company's discretion.","Agreement filed as Exhibit 10.1; shelf registration on Form S-3 filed same day."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-120164","json":"https://secwatch.observer/filing/0001193125-26-120164.json","markdown":"https://secwatch.observer/filing/0001193125-26-120164.md","text":"https://secwatch.observer/filing/0001193125-26-120164.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1774857/000119312526120164/0001193125-26-120164-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1774857/000119312526120164/ck0001774857-20260323.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T09:14:08.095681+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e9632d0abc292eaa2a0b483fd01276d201e881a0","claim":"Aardvark Therapeutics, Inc. entered into Equity Distribution Agreement with Piper Sandler & Co. valued at up to $150,000,000 (effective 2026-03-23).","evidence_excerpt":"On March 23, 2026, Aardvark Therapeutics, Inc. (the “Company”) entered into an Equity Distribution Agreement (the “Equity Distribution Agreement”) with Piper Sandler & Co., as sales agent (the “Agent”), pursuant to which the Company may, from time to time, in its sole discretion, offer and sell through or to the Agent, shares (“Shares”) of its common stock, par value $0.00001 per share.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1774857/000119312526120164/0001193125-26-120164-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"atm program"},{"label":"Counterparty","value":"Piper Sandler & Co."},{"label":"Value","value":"up to $150,000,000"},{"label":"Effective","value":"2026-03-23"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}